[Bronchoalveolar lavage (BAL) in pulmonary sarcoidosis. II. Changes in BAL cellular morphology and respiratory function in patients with sarcoidosis treated with prednisone].
BAL and respiratory function were analysed in 26 patients with sarcoidosis (age range 22-48 years) before and after a 12 month steroid therapy trial. 11 patients were in the active stage according to the BAL criteria. After treatment a significant decrease in BAL lymphocytosis was found (a decrease from 31.4% to 22.8%). A significant increase in TLC, DLCOSB and D/VA mean values was found. The effect of steroid therapy was similar in the active and non-active stage of the disease. The authors found BAL useful in monitoring of therapy.
Ziora
D
D
Kliniki Ftyzjopneumonologicznej Sl.A.M, Zabrzu.
Oklek
K
K
D000328:Adult; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011241:Prednisone / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D012507:Sarcoidosis / Q000175:diagnosis / Q000188:drug therapy*
D011241:Prednisone
Popłuczyny oskrzelowo-pecherzykowe (BAL) u chorych na sarkoidoze. Cześć II. Zmiany składu komórkowego BAL i czynnosci układu oddechowego u chorych na sarkoidoze leczonych prednizonem.